Browsing Tag

ADG106

Adagene Announces First Patients with Advanced Non-Small Cell Lung Cancer Dosed in…

Eli Pacheco Jan 13, 2022 0

SAN DIEGO and SUZHOU, China, Jan. 13, 2022 (GLOBE NEWSWIRE) -- Adagene Inc. (“Adagene”) (Nasdaq: ADAG) today announced that the first patients have been dosed in a phase 1b/2 clinical…

Health

Adagene Establishes Collaboration for Clinical Trial of ADG106 in Combination with …

Eli Pacheco Oct 27, 2021 0

- Phase 1b/2 trial to be conducted at the National University Cancer Institute, Singapore and the National Cancer Centre Singapore, in Collaboration with the Singapore Translational Cancer…